What is NDC 68084-907?

68084-907 is the product NDC for Mycophenolic Acid, Mycophenolate sodium 180 mg/1 tablet, delayed release, listed with the FDA by American Health Packaging. It has 1 package NDC, shown above in 10- and 11-digit form.

American Health Packaging, NDC labeler code 68084. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Mycophenolic Acid?

34 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Mycophenolic Acid NDC 68084-907 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68084-907Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68084-0907Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68084-907-21	6808409072168084090721	30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-907-21) / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (68084-907-11)Marketed from Feb 2, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mycophenolic Acid
Generic name (nonproprietary): mycophenolic acid
Active ingredients: Mycophenolate sodium — 180 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: American Health PackagingNDC labeler code 68084
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091558
Marketing start: Feb 2, 2015
Listing expires: Dec 31, 2027
Identifiers: Product ID 68084-907_5799bba8-e17a-d73f-e063-6294a90acde4SPL ID 5799bba8-e17a-d73f-e063-6294a90acde4SPL set ID 26b31126-4262-4a15-8a16-234c86763176RxCUI 485020, 485023UNII WX877SQI1G
Pharmacologic class: Antimetabolite Immunosuppressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468084090721 followed by a unit qualifier and the quantity

Package 68084-0907-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 27, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Mycophenolic acid delayed-release tablets are an antimetabolite immunosuppressant indicated for prophylaxis of organ rejection in adult patients receiving kidney transplants and in pediatric patients at least 5 years of age and older who are at least 6 months post kidney transplant. (1.1) Use in combination with cyclosporine and corticosteroids. (1.1) Limitations of Use: Mycophenolic acid delayed release tablets and mycophenolate mofetil tablets and capsules should not be used interchangeably. (1.2) 1.1 Prophylaxis of Organ Rejection in Kidney Transplant Mycophenolic acid delayed-release tablets are indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transpl…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68084-907

What is NDC 68084-907?: 68084-907 is the product NDC for Mycophenolic Acid, Mycophenolate sodium 180 mg/1 tablet, delayed release, listed with the FDA by American Health Packaging. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Mycophenolic Acid.
What is the active ingredient?: Mycophenolate sodium.
Who is the labeler?: American Health Packaging, NDC labeler code 68084. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Mycophenolic Acid?: 34 other product NDCs are listed under this name. See all Mycophenolic Acid NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Mycophenolic Acid NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
mycophenolic acid	Mycophenolate sodium 180 mg/1	Tablet, Delayed releaseOral	Stellon Biotech Inc.	85972-161	85972-0161-12
mycophenolic acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	Stellon Biotech Inc.	85972-162	85972-0162-12
Mycophenolic Acid	Mycophenolate sodium 180 mg/1	Tablet, Delayed releaseOral	Ascend Laboratories, LLC	67877-928	67877-0928-0567877-0928-1267877-0928-38
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	Ascend Laboratories, LLC	67877-929	67877-0929-0567877-0929-1267877-0929-38
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	REMEDYREPACK INC.	70518-4391	70518-4391-00
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	Major Pharmaceuticals	0904-7372	00904-7372-0400904-7372-61
Mycophenolic Acid	Mycophenolate sodium 180 mg/1	Tablet, Delayed releaseOral	Biocon Pharma Inc.	70377-126	70377-0126-11
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	Biocon Pharma Inc.	70377-127	70377-0127-11
Mycophenolic Acid	Mycophenolate sodium 180 mg/1	Tablet, Delayed releaseOral	Novugen Pharma (USA) LLC.	82293-012	82293-0012-10
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	Novugen Pharma (USA) LLC.	82293-013	82293-0013-10

All 35 Mycophenolic Acid NDCs

Other NDCs under ANDA 091558

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091558
Product	Strength	Form · route	Labeler	Product NDC
Mycophenolic Acid	Mycophenolate sodium 180 mg/1	Tablet, Delayed releaseOral	Major Pharmaceuticals	0904-6785
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	Major Pharmaceuticals	0904-6786
Mycophenolic Acid	Mycophenolate sodium 180 mg/1	Tablet, Delayed releaseOral	Golden State Medical Supply, Inc.	60429-016
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	Golden State Medical Supply, Inc.	60429-017
Mycophenolic Acid	Mycophenolate sodium 180 mg/1	Tablet, Delayed releaseOral	Apotex Corp	60505-2965
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	Apotex Corp	60505-2966
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	American Health Packaging	68084-918